{"id":249292,"date":"2018-08-02T10:14:03","date_gmt":"2018-08-02T10:14:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=249292"},"modified":"2018-08-02T10:14:03","modified_gmt":"2018-08-02T10:14:03","slug":"asthma-copd-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/asthma-copd-market-2018-global-trend-segmentation-and-opportunities-forecast-to-2023_249292.html","title":{"rendered":"Asthma & COPD Market 2018 Global Trend, Segmentation And Opportunities Forecast To 2023"},"content":{"rendered":"
\n
“Asthma & COPD”<\/div>\n<\/div>\n
Asthma & COPD -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023<\/div>\n

Asthma & COPD <\/strong>Industry<\/strong><\/a><\/p>\n

Description<\/strong><\/p>\n

Wiseguyreports.Com Adds “Asthma & COPD -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” <\/strong>To Its Research Database<\/p>\n

This report studies the global Asthma & COPD market status and forecast, categorizes the global Asthma & COPD market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.<\/p>\n

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway. 
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath. <\/p>\n

Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions. <\/p>\n

The major manufacturers covered in this report <\/p>\n

GSK <\/strong>
Novartis <\/strong>
Merck <\/strong>
Abbott <\/strong>
Boehringer Ingelheim <\/strong>
AstraZeneca <\/strong>
Roche <\/strong>
Teva <\/strong>
Vectura <\/strong>
Pfizer <\/strong>
Mylan <\/strong>
Allergan <\/strong>
Cipla <\/strong>
Akorn<\/strong><\/p>\n

Request for Sample Report @ https:\/\/www.wiseguyreports.com\/sample-request\/3317833-global-asthma-copd-market-research-report-2018<\/a> <\/strong><\/p>\n

Geographically<\/strong>, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India<\/p>\n

On the basis of product<\/strong>, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Anti-inflammatory Drugs 
Bronchodilator Monotherapy 
Combination Drugs <\/p>\n

On the basis of the end users\/applications<\/strong>, this report focuses on the status and outlook for major applications\/end users, consumption (sales), market share and growth rate for each application, including 
Hospital Pharmacies 
Private Clinics 
Drug Stores 
Retail Pharmacies 
E-Commerce<\/p>\n

For the data information by region,<\/strong> company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.<\/p>\n

Key Stakeholders 
Asthma & COPD Manufacturers 
Asthma & COPD Distributors\/Traders\/Wholesalers 
Asthma & COPD Subcomponent Manufacturers 
Industry Association 
Downstream Vendors<\/p>\n

Leave a Query @ https:\/\/www.wiseguyreports.com\/enquiry\/3317833-global-asthma-copd-market-research-report-2018<\/a> <\/strong><\/p>\n

 <\/p>\n

Table of Contents<\/strong><\/p>\n

Global Asthma & COPD Market Research Report 2018 
1 Asthma & COPD Market Overview 
1.1 Product Overview and Scope of Asthma & COPD 
1.2 Asthma & COPD Segment by Type (Product Category) 
1.2.1 Global Asthma & COPD Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Asthma & COPD Production Market Share by Type (Product Category) in 2017 
1.2.3 Anti-inflammatory Drugs 
1.2.4 Bronchodilator Monotherapy 
1.2.5 Combination Drugs 
1.3 Global Asthma & COPD Segment by Application 
1.3.1 Asthma & COPD Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Hospital Pharmacies 
1.3.3 Private Clinics 
1.3.4 Drug Stores 
1.3.5 Retail Pharmacies 
1.3.6 E-Commerce 
1.4 Global Asthma & COPD Market by Region (2013-2025) 
1.4.1 Global Asthma & COPD Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Asthma & COPD (2013-2025) 
1.5.1 Global Asthma & COPD Revenue Status and Outlook (2013-2025) 
1.5.2 Global Asthma & COPD Capacity, Production Status and Outlook (2013-2025)<\/p>\n

….<\/p>\n

7 Global Asthma & COPD Manufacturers Profiles\/Analysis 
7.1 GSK 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Asthma & COPD Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 GSK Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business\/Business Overview 
7.2 Novartis 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Asthma & COPD Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Novartis Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business\/Business Overview 
7.3 Merck 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Asthma & COPD Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Merck Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business\/Business Overview 
7.4 Abbott 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Asthma & COPD Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Abbott Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business\/Business Overview 
7.5 Boehringer Ingelheim 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Asthma & COPD Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Boehringer Ingelheim Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business\/Business Overview 
7.6 AstraZeneca 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Asthma & COPD Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 AstraZeneca Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business\/Business Overview 
7.7 Roche 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Asthma & COPD Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Roche Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business\/Business Overview 
7.8 Teva 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 Asthma & COPD Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 Teva Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.8.4 Main Business\/Business Overview 
7.9 Vectura 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.9.2 Asthma & COPD Product Category, Application and Specification 
7.9.2.1 Product A 
7.9.2.2 Product B 
7.9.3 Vectura Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.9.4 Main Business\/Business Overview 
7.10 Pfizer 
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.10.2 Asthma & COPD Product Category, Application and Specification 
7.10.2.1 Product A 
7.10.2.2 Product B 
7.10.3 Pfizer Asthma & COPD Capacity, Production, Revenue, Price and Gross Margin (2013-2020) 
7.10.4 Main Business\/Business Overview 
7.11 Mylan 
7.12 Allergan 
7.13 Cipla 
7.14 Akorn<\/p>\n

Buy Now @ https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=3317833<\/a> <\/strong><\/p>\n

Continued…                        <\/strong><\/p>\n

 <\/strong><\/p>\n

Contact Us: <\/strong>Sales@Wiseguyreports.Com<\/strong><\/a> Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)<\/strong><\/p>\n

 <\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Asthma & COPD” Asthma & COPD -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Asthma & COPD Industry Description Wiseguyreports.Com Adds “Asthma & COPD -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-249292","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/249292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=249292"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/249292\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=249292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=249292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=249292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}